CAS号:97322-87-7
品名:曲格列酮Troglitazone
中文别名:5-[[4-[(3,4-二氢-6-羟基-2,5,7,8-四甲基-2H-1-苯并吡喃-2-基)甲氧基]苯基]甲基]-2,4-噻唑烷二酮;特洛格列酮;(+/-)-5-[4-[(6-羟基-2,5,7,8-四甲基苯并二氢吡喃-2-基)甲氧基]苄基]-2,4-噻唑烷二酮;
英文别名:Prelay;Romglizone;5-[4-[(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]-benzyl]-2,4-thiazolidinedione;5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazolidine;5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)-benzyl]thiazolidine-2,4-dione;Rezulin(TN);CS-045;Rezulin;Romozin;Noscal;5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;Resulin;
分子式:C24H27NO5S
分子量:441.54
精确质量:441.161
Psa:110.16
RTECS号:XJ5813130
UNII号:I66ZZ0ZN0E
外观与性状:黄色固体
密度:1.266g/cm3
沸点:657ºC at 760mmHg
熔点:184-186°C
闪点:351.2ºC
稳定性:This material is stable if stored as directed.
储存条件:This product should be stored at room temperature. It should be kept in a tightly closed container.
安全说明:S22-S24/25
WGK Germany:2
简介:Troglitazone(Rezulin,Resulin,Romozin,Noscal)isanantidiabeticandanti-inflammatorydrug,andamemberofthedrugclassofthethiazolidinediones.Itwasprescribedforpatientswithdiabetesmellitustype2.ItwasdevelopedbyDaiichiSankyo(Japan).IntheUnitedStates,itwasintroducedandmanufacturedbyParke-Davisinthelate1990s,butturnedouttobeassociatedwithanidiosyncraticreactionleadingtodrug-inducedhepatitis.TheF.D.A.medicalofficerassignedtoevaluatetroglitazone,JohnGueriguian,didnotrecommenditsapprovalduetopotentialhighlivertoxicity;Parke-DaviscomplainedtotheFDAandGuerigianwassubsequentlyremovedfromhispost.AfullpanelofexpertsapproveditinJanuary1997.Oncetheprevalenceofadverselivereffectsbecameknown,troglitazonewaswithdrawnfromtheBritishmarketinDecember1997,fromtheUnitedStatesmarketin2000,andfromtheJapanesemarketsoonafterwards.ItdidnotgetapprovalintherestofEurope.
用途:噻唑烷酮类口服抗高血糖药。用于因产生耐受而单独使用胰岛素难控制的Ⅱ型糖尿病。